/ CompletedNot Applicable [Translation] Exenatide Study to Reduce Cardiovascular Events
本研究比较包括每周一次注射用艾塞那肽的常规治疗与常规治疗对主要心血管结局的影响,通过心血管相关的死亡、非致死性心肌梗塞(MI)或非致死性中风的主要复合终点对主要心血管结局进行测定。
[Translation] This study compared the effects of treatment consisting of once-weekly injections of exenatide with treatment as usual care on major cardiovascular outcomes measured by the primary composite endpoint of cardiovascular-related death, nonfatal myocardial infarction (MI), or nonfatal stroke.
100 Clinical Results associated with Amylin Ohio LLC
0 Patents (Medical) associated with Amylin Ohio LLC
100 Deals associated with Amylin Ohio LLC
100 Translational Medicine associated with Amylin Ohio LLC